Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 239

The DOI matches its Crossref record.

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.

Mason, W P, Grovas, A, Halpern, S, Dunkel, I J, Garvin, J, Heller, G, Rosenblum, M, Gardner, S, Lyden, D, Sands, S, Puccetti, D, Lindsley, K, Merchant, T E, O'Malley, B, Bayer, L, Petriccione, M M, Allen, J, Finlay, J L·1998·Journal of Clinical Oncology

Abstract

PURPOSE: To evaluate a strategy that avoids radiotherapy in children less than 6 years of age with newly diagnosed malignant brain tumors, by administering myeloablative consolidation chemotherapy with autologous bone marrow reconstitution (ABMR) after maximal surgical resection and conventional induction chemotherapy. PATIENTS AND METHODS: Between March 1991 and April 1995, 62 children (median age, 30 months) with newly diagnosed malignant brain tumors were enrolled onto this trial. Children received conventional induction chemotherapy with vincristine, cisplatin, cyclophosphamide, and etoposide, repeated every 3 weeks for five cycles. Children without disease progression on induction chemotherapy were offered consolidation with myeloablative chemotherapy that incorporated carboplatin, thiotepa, and etoposide followed by ABMR. Irradiation was used only for residual tumor at consolidation or for progressive/recurrent disease. RESULTS: Induction chemotherapy was well tolerated by most patients; however, progression was noted in 17 children (27%) and four (6%) died of treatment complications. Of 37 children who received consolidation chemotherapy with ABMR, 15 are free of disease progression (median post-ABMR without further treatment, >44 months). The remaining 22 all progressed within 15 months of ABMR; three of 37 (8%) died of treatment-related complications. The 3-year overall survival (OS) and event-free survival (EFS) rates from diagnosis for all children are 40% (95% confidence interval [CI], 28% to 52%) and 25% (95% CI, 13% to 37%), respectively. Radiotherapy was administered to 19 of 62 children: 17 for progressive disease (PD) and two for residual disease at the time of ABMR. CONCLUSION: A significant proportion of children with malignant brain tumors can avoid radiotherapy and prolonged maintenance chemotherapy yet still achieve durable remission with this brief intensive chemotherapy regimen.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.1998.16.1.210

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 239

Metadata

Authors
Mason, W. P., Grovas, A., Halpern, S., Dunkel, I. J., Garvin, J., Heller, G., Rosenblum, M., Gardner, S., Lyden, D., Sands, S., Puccetti, D., Lindsley, K., Merchant, T. E., O'Malley, B., Bayer, L., Petriccione, M. M., Allen, J., & Finlay, J. L.
Venue
Journal of Clinical Oncology
Published
1998-01
Volume
16
Issue
1
Pages
210-221
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2180612211
Cited by
239
References
0
FWCI
10.33
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. https://app.cochat.ai/papers/10.1200/jco.1998.16.1.210
The paper
Mason, W. P., Grovas, A., Halpern, S., Dunkel, I. J., Garvin, J., Heller, G., Rosenblum, M., Gardner, S., Lyden, D., Sands, S., Puccetti, D., Lindsley, K., Merchant, T. E., O'Malley, B., Bayer, L., Petriccione, M. M., Allen, J., & Finlay, J. L. (1998). Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1998.16.1.210

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.